It is characterized by elevated numbers of immature atypical mast cells (> 10% metachromatic blasts) without meeting the full criteria for systemic mastocytosis, notably lacking CD2/CD25 expression, D816V KIT mutation, and focal dense mast cell infiltrates [4]. This evidence concerns the gene CD2 and systemic mastocytosis.